Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid is a synthetic small molecule with the chemical formula C24H21NO4 and a molecular weight of approximately 387.43 g/mol[1][2][5]. It is classified as an aromatic compound containing a dibenzylamino group attached to a phenyl ring and a dioxobutanoic acid moiety. The compound has been cataloged in several chemical and drug databases (DrugBank ID: DB08147; PubChem CID: 510684; ChEMBL ID: CHEMBL1234135)[2][3]. There are no approved therapeutic indications or clinical trials reported for this molecule, and it is considered experimental[3]. No mechanism of action or biological target has been established in the literature or major drug databases.
- Other names
- 4-(3-(dibenzylamino)phenyl)-2,4-dioxobutanoic acidRMWVENXKUQXLPW-UHFFFAOYSA-N
Beyond the preview
Go deeper on 4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid.